Study to assess the efficacy and safety of treatment with FOLFIRI-aflibercept compared to initial treatment with FOLFIRI-aflibercept (for 6 cycles) followed by maintenance with 5FU-aflibercept, in an elderly population with metastatic colorectal cancer after failure of an oxaliplatin-based regimen
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2536279
下载链接
链接失效反馈官方服务：
资源简介：
Primary objectives: To assess the non inferiority of aflibercept + 5FU/LV as maintenance vs aflibercept+ FOLFIRI with progression free survival (PFS) as the primary outcome parameterin elderly patients (≥70 years).
Primary endpoints: Progression-free survival
创建时间：
2017-05-15
